STOCK TITAN

Acadia Healthcare (NASDAQ: ACHC) director awarded 6,331-share stock grant

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Harris Patrice A reported acquisition or exercise transactions in this Form 4 filing.

Acadia Healthcare Company, Inc. director Patrice A. Harris reported receiving a grant of 6,331 shares of Common Stock as compensation. The award was recorded at a price of $0.00 per share and increased her directly held stake to 17,914 shares.

The granted shares will vest over three years in equal yearly installments beginning on May 6, 2027, meaning the award is subject to continued service or other vesting conditions rather than being fully owned immediately. This filing reflects a routine equity compensation grant, not an open-market purchase or sale.

Positive

  • None.

Negative

  • None.
Insider Harris Patrice A
Role Director
Type Security Shares Price Value
Grant/Award Common Stock 6,331 $0.00 $0.00
Holdings After Transaction: Common Stock — 17,914 shares (Direct)
Footnotes (1)
  1. F1. Shares will vest over a 3-year period in equal yearly installments beginning May 6, 2027.
Shares granted 6,331 shares Common Stock grant on May 6, 2026
Price per share $0.00 per share Equity compensation award, non-market transaction
Shares held after 17,914 shares Total direct holdings following grant
Vesting period 3 years Equal yearly installments starting May 6, 2027
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
Common Stock financial
"security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
vest over a 3-year period financial
"Shares will vest over a 3-year period in equal yearly installments"
non-derivative financial
"transaction_type: non-derivative"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did ACHC director Patrice A. Harris report?

Director Patrice A. Harris reported receiving a grant of 6,331 shares of Acadia Healthcare Common Stock. The shares were awarded at $0.00 per share as equity compensation, increasing her directly held position to 17,914 shares after the transaction.

Was the ACHC Patrice A. Harris Form 4 a market buy or sell?

The Form 4 for Patrice A. Harris does not show a market buy or sell. It reports a compensation-related grant classified as a “Grant, award, or other acquisition,” with 6,331 shares awarded at $0.00 per share instead of an open-market trade.

How many ACHC shares does Patrice A. Harris hold after this grant?

After receiving the 6,331-share award, Patrice A. Harris directly holds 17,914 shares of Acadia Healthcare Common Stock. This total reflects her position following the reported non-derivative equity grant on May 6, 2026, as disclosed in the Form 4 filing.

What is the vesting schedule for Patrice A. Harris’s new ACHC share grant?

The 6,331-share grant to Patrice A. Harris vests over three years in equal yearly installments. Vesting begins on May 6, 2027, meaning the award becomes fully earned gradually rather than immediately, aligning ongoing ownership with continued service on Acadia Healthcare’s board.

Does the ACHC Form 4 for Patrice A. Harris involve derivative securities?

No, the reported transaction for Patrice A. Harris involves non-derivative Common Stock only. The filing lists no option or other derivative exercises, and the derivative position summary is empty, indicating this event is solely a stock grant rather than an option-related transaction.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Harris Patrice A

(Last)(First)(Middle)
4020 ASPEN GROVE DRIVE, SUITE 900

(Street)
FRANKLIN TENNESSEE 37067

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Acadia Healthcare Company, Inc. [ ACHC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/06/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/06/2026A6,331(1)A$0.017,914D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Shares will vest over a 3-year period in equal yearly installments beginning May 6, 2027.
/s/ Brian Farley as Attorney in Fact for Patrice A. Harris05/08/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)